Panalpina’s new, purpose-built logistics center in Singapore, where many of the world’s top pharmaceutical companies have manufacturing facilities, is now GDP-certified
After Bogotá in August, Panalpina has now obtained a Good Distribution Practice (GDP) certification for its new logistics centre in Singapore, where many of the world’s top pharmaceutical companies have manufacturing facilities.
The GDP quality assurance standard includes stringent requirements for the handling, storage and distribution of pharmaceuticals, and this most recent certification brings the number of Panalpina locations certified globally to 32.
The GDP certificate was issued by Singapore’s Health Sciences Authority (HSA) following a rigorous inspection. To be granted GDP certification in Singapore, companies must demonstrate compliance with HSA GDP guidelines, which are based on the most important global guidelines.
With the new GDP certification, Panalpina is authorised to store, handle and distribute medicines in the local market and to ship them abroad on behalf of pharmaceutical companies.
“The pharmaceutical sector in Singapore has developed enormously since 2000 and the companies are increasingly outsourcing the logistics for their highly sensitive products,” says Gino Marzola, Panalpina’s managing director for Singapore and Malaysia.
“Healthcare supply chains have a zero-fault tolerance, and the GDP certification for our brand-new facility demonstrates that we can meet that requirement. We also give pharmaceutical companies access to a global, quality distribution network for their products,” Marzola adds.
The pharmaceutical sector is particularly important to Singapore. According to the Singapore Economic Development Board (EDB), eight of the top ten pharmaceutical companies have a presence in the city-state, manufacturing four of the top ten drugs by global revenue.
In 2016, the sector produced more than SGD 16 billion (USD 11.6 billion) worth of products for global markets.
With many pharmaceutical companies demanding that the business units from third-party logistics providers (3PLs) handling their products are certified according to GDP, Panalpina notes that maintaining product quality and safety of pharmaceuticals in the supply chain is highly critical.
“In line with this, the company has taken strong initiatives to exceed the expectations of healthcare customers,” Panalpina adds.